Skip to main content
. Author manuscript; available in PMC: 2019 Jan 22.
Published in final edited form as: Cancer Immunol Res. 2018 Apr 13;6(6):645–657. doi: 10.1158/2326-6066.CIR-17-0554

Figure 7. Adoptive transfer of IL17a sufficient CD4+ T cells reverses decreased tumor latency and metastasis in Pts4d/dIl17a−/− mice.

Figure 7

15 × 106 wild type CD4+ T cells were adoptively transferred to Pts4d/dIl17a−/− mice at 2.5 and 5 months of age. (A) Representative H&E staining of lung tumors in the indicated groups of mice (inset 4× magnification). scale bar = 100 μm. (B) Frequency of lung tumor and stomach metastases in Pts4d/d and Pts4d/dIl17a−/−, Pts4d/dIl17a−/− (+WT CD4) mice at 7 and 8 months. (C) Relative abundance of Th17 cells, (D) ICC detection of IFNγ and IL17A in lung CD4+ and CD8+ T cells (CTLs) respectively. (E) Relative expression of CD103 in lung DCs (CD11c+CD11b) in the same groups of mice. (F) ICC detection of IFNγ in lung CD8+ T cells (CTLs) in mediastinal lymph nodes in the same groups of mice at 7 months of age. (G) Relative expression of CTLA in CD4+ T cells in mediastinal lymph nodes of the same groups of mice. Data are mean ± SEM and representative of two independent experiments (C – G); ** P < 0.01, * P < 0.05 as determined by the Chi-square test (B) or the one-way ANOVA and Bonferroni’s Multiple Comparison test (C-G).